For the Inventor, By the Inventor

Enter assignee name

Calgary, Canada

Enveric Biosciences Canada Inc.

USPTO Granted Patents = 25

Forward Citations = 2

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Peter James Facchini (25 out of 39 patents)

Jillian M Hagel (25 out of 26 patents)

Chang-Chun Ling (12 out of 17 patents)

4. Kaveh Matinkhoo (11 out of 12 patents)

5. David James Press (9 out of 9 patents)

6. Glynnis Elizabeth Jensen (8 out of 8 patents)

7. Ye Cai (6 out of 6 patents)

8. Jessica Bik-Jing Lee (4 out of 4 patents)

9. Xue Chen (1 out of 5 patents)

Core Competencies:

Psilocybin Derivatives

Tryptamine Derivatives

Heterocyclic Compounds

Carboxylated Compounds

Aminated Compounds

Multi-substituent Derivatives

N-heterocycle Compounds

Mescaline Derivatives

Halogenated Compounds

Prenylated Compounds

Glycosylated Compounds

C-carbonothioate Compounds

25 patents: Sort by Forward Citations

1. 12605361 - Carboxylated psilocybin derivatives and methods of using (2026-04-21),

2. 12577232 - N-heterocycle substituted tryptamine derivatives and methods of using (2026-03-17),

3. 12492179 - Substituted ethylamine fused heterocyclic mescaline derivatives (2025-12-09),

4. 12428408 - Fused heterocyclic mescaline derivatives (2025-09-30),

5. 12378195 - Aminated psilocybin derivatives and methods of using (2025-08-05),

6. 12358885 - Substituted n-propylamine fused heterocyclic mescaline derivatives (2025-07-15),

7. 12338231 - N-heterocycle substituted tryptamine derivatives and methods of using (2025-06-24),

8. 12195439 - C1-substituted isopropylamine fused heterocyclic mescaline derivatives (2025-01-14),

9. 12187679 - Hydroxylated psilocybin derivatives and methods of using (2025-01-07),

10. 12138276 - Halogenated psilocybin derivatives and methods of using (2024-11-12),

11. 12133856 - Multi-substituent psilocybin derivatives and methods of using (2024-11-05),

12. 12128058 - Multi-substituent psilocybin derivatives and methods of using (2024-10-29),

13. 12077498 - C4-carboxylic acid-substituted tryptamine derivatives and methods of using (2024-09-03),

14. 12065404 - C4-carboxylic acid-substituted tryptamine derivatives and methods of using (2024-08-20),

15. 11998557 - Halogenated psilocybin derivatives and methods of using (2024-06-04),

Company Overview

Enveric Biosciences Canada Inc. is a biotechnology company based in Calgary, specializing in the development of innovative therapies for mental health and neurological disorders. The organization focuses on leveraging advanced research in psychedelic compounds and their potential therapeutic applications. With a commitment to scientific rigor, Enveric aims to address unmet medical needs through its pioneering research and development efforts, contributing to the evolving landscape of mental health treatment options.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

25 Patents

#40 in Calgary

#582 in Canada

#25,730 in the World

Calgary, Canada

Enveric Biosciences Canada Inc.

Forward Citations = 2

9 inventors:

Peter James Facchini (25 out of 39 patents)

Jillian M Hagel (25 out of 26 patents)

Chang-Chun Ling (12 out of 17 patents)

4. Kaveh Matinkhoo (11 out of 12 patents)

5. David James Press (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Enveric Biosciences Canada Inc.. Retrieved from https://idiyas.com/company/enveric-biosciences-canada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…